FDA Inspection 1094419 — Andy-Oxy Co. Inc
The FDA completed an inspection of Andy-Oxy Co. Inc on April 17, 2019 in Asheville, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 17, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Asheville, NC (United States)